Product Description
| Brand | InBios |
| Sample Type | Ulcerative skin lesions |
| Pack Size | 25T |
| CAT No | CL025 |
The CLDetect Rapid Test is a qualitative,in vitroimmunochromatographic assay for the rapid detection of Leishmania species antigen in ulcerative skin lesions. The test is intended for use with dental broach samples from less than four month old ulcerative skin lesions that are obtained from patients with suspected cutaneous leishmaniasis (CL). The test targets the peroxidoxin antigen of Leishmania species that may cause CL.
Fast and Reliable Leishmaniasis DetectionThe InBios CL Detect Rapid Test offers results in just 30 minutes, enabling swift clinical decision-making. Its lateral flow technology ensures dependable detection of Leishmania antigens in skin lesion samples. With sensitivity and specificity that generally exceed 85%, especially for L. major, clinicians can trust the accuracy for various geographic regions.
Designed for Field and Clinic UseThis rapid test kit is specifically built for deployment in both remote and clinical settings. Its manual operation requires no electricity or advanced apparatus, while its portable and robust design makes it exceptionally field-friendly. The kit's clear visual results ensure usability in diverse environments.
User-Friendly and SafeEach kit contains all necessary components for single-use testing: a test device, buffer solution, swab, and clear instructions. The process involves minimal steps to reduce errors, and the compact, sealed packaging strengthens biosafety and simplifies transport or storage for up to 18 months.
FAQ's of InBios CL Detect Rapid Test for Cutaneous Leishmaniasis:
Q: How is the InBios CL Detect Rapid Test performed?
A: To use the test, a healthcare professional collects a sample from the lesion using the provided swab, mixes it with the supplied buffer, and applies the mixture to the test device. After 30 minutes, results are determined by the appearance of color lines on the test cassette.
Q: What samples are suitable for the InBios CL Detect Rapid Test?
A: The test is validated for skin lesion exudate or tissue samples taken directly from suspected cutaneous leishmaniasis lesions.
Q: When should this rapid test be used?
A: This test is intended for situations where quick on-site diagnosis is needed, such as in clinics, field surveys, or remote healthcare facilities where Cutaneous Leishmaniasis is suspected.
Q: Where can the test be deployed or stored?
A: The kit is portable and can be used in a clinic, hospital, or the field. It must be stored at temperatures between 2-30C, and should not be frozen.
Q: What is the benefit of using this test compared to traditional methods?
A: The InBios CL Detect Rapid Test provides fast, reliable results without the need for complex laboratory infrastructure, making it ideal for early diagnosis and timely management of Cutaneous Leishmaniasis.
Q: How accurate is the test for diagnosing Cutaneous Leishmaniasis?
A: The test generally offers more than 90% accuracy, with sensitivity and specificity varying by region and sample type, being especially high for cases of L. major.
Q: What is included in the test kit and is it reusable?
A: Each kit includes a test device, extraction buffer, swab, and instructions. The test is designed for single use only and should be properly disposed of after use.